DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Lencioni R, Llovet JM, Han G. et al.
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: the SPACE trial.
J Hepatol 2016;
64 (05) 1090-1098
We do not assume any responsibility for the contents of the web pages of other providers.